By using several cancer cell lines and primary samples, Ames et al. demonstrated that the CSCs (identified as CD24+/CD44+/CD133+/ALDHbright) present higher levels of MICA/MICB, Fas and DR5, NK activator ligands, as compared to non-CSCs [77]. This evidence concerns the gene FAS and cancer.